Scott Mendel, President & CEO at GenMark Diagnostics, Inc. (GNMK), sold 129,950 shares at $14.23 ($1.8M) on 2021-01-25, disclosed to the SEC on 2021-01-25.
Open-market sale of $1.8M GNMK by President & CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.23 | 64,975 | $925K | 50.0% |
| 2 | $14.23 | 64,975 | $925K | 50.0% |
| Total | $14.23 avg | 129,950 | $1.8M | 100% |
| Filing → |
| GNMK | SELL | 2021-01-21 | $727K | — | Filing → |
| GNMK | SELL | 2020-11-25 | $137K | — | Filing → |
| GNMK | SELL | 2020-11-20 | $110K | — | Filing → |